Ivan Hirsch

Prague, PR, Czech Republic

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

STING agonists trigger monocyte death via apoptosis, pyroptosis, caspase-8 activation and mitochondrial dysfunction.

STING agonists trigger monocyte death via apoptosis, pyroptosis, caspase-8 activation and mitochondrial dysfunction.

Journal: Cell death discovery

Published: April 14, 2025

UBE2O, a host ubiquitin-conjugating enzyme, is a key regulator of hepatitis B virus maturation and egress.

UBE2O, a host ubiquitin-conjugating enzyme, is a key regulator of hepatitis B virus maturation and egress.

Journal: The Journal of biological chemistry

Published: April 14, 2025

Prophylactic vaccines against cancers of non-infectious origin: a dream or a real possibility?

Prophylactic vaccines against cancers of non-infectious origin: a dream or a real possibility?

Journal: Central European journal of public health

Published: December 01, 2021

ATM-Dependent Phosphorylation of Hepatitis B Core Protein in Response to Genotoxic Stress.

ATM-Dependent Phosphorylation of Hepatitis B Core Protein in Response to Genotoxic Stress.

Journal: Viruses

Published: August 31, 2021

TLR4-Mediated Recognition of Mouse Polyomavirus Promotes Cancer-Associated Fibroblast-Like Phenotype and Cell Invasiveness.

TLR4-Mediated Recognition of Mouse Polyomavirus Promotes Cancer-Associated Fibroblast-Like Phenotype and Cell Invasiveness.

Journal: Cancers

Published: March 08, 2021

Hepatitis B Core Protein Is Post-Translationally Modified through K29-Linked Ubiquitination.

Hepatitis B Core Protein Is Post-Translationally Modified through K29-Linked Ubiquitination.

Journal: Cells

Published: September 30, 2020

Toll-like receptor dual-acting agonists are potent inducers of PBMC-produced cytokines that inhibit hepatitis B virus production in primary human hepatocytes.

Toll-like receptor dual-acting agonists are potent inducers of PBMC-produced cytokines that inhibit hepatitis B virus production in primary human hepatocytes.

Journal: Scientific reports

Published: January 28, 2020

Expression of TIM-3 on Plasmacytoid Dendritic Cells as a Predictive Biomarker of Decline in HIV-1 RNA Level during ART.

Expression of TIM-3 on Plasmacytoid Dendritic Cells as a Predictive Biomarker of Decline in HIV-1 RNA Level during ART.

Journal: Viruses

Published: March 07, 2018

Hepatitis B Virus Evasion From Cyclic Guanosine Monophosphate-Adenosine Monophosphate Synthase Sensing in Human Hepatocytes.

Hepatitis B Virus Evasion From Cyclic Guanosine Monophosphate-Adenosine Monophosphate Synthase Sensing in Human Hepatocytes.

Journal: Hepatology (Baltimore, Md.)

Published: December 14, 2017

The MEK1/2-ERK Pathway Inhibits Type I IFN Production in Plasmacytoid Dendritic Cells.

The MEK1/2-ERK Pathway Inhibits Type I IFN Production in Plasmacytoid Dendritic Cells.

Journal: Frontiers in immunology

Published: November 20, 2017

PRMT5: A novel regulator of Hepatitis B virus replication and an arginine methylase of HBV core.

PRMT5: A novel regulator of Hepatitis B virus replication and an arginine methylase of HBV core.

Journal: PloS one

Published: July 03, 2017

Cross Talk between Inhibitory Immunoreceptor Tyrosine-Based Activation Motif-Signaling and Toll-Like Receptor Pathways in Macrophages and Dendritic Cells.

Cross Talk between Inhibitory Immunoreceptor Tyrosine-Based Activation Motif-Signaling and Toll-Like Receptor Pathways in Macrophages and Dendritic Cells.

Journal: Frontiers in immunology

Published: January 15, 2017

Showing 1-12 of 19

Last Updated: 09/26/2026